These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

827 related items for PubMed ID: 28130808

  • 1. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and 123 I-metaiodobenzylguanidine myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
    Kobayashi S, Makino K, Hatakeyama S, Ishii T, Tateno M, Iwamoto T, Tsujino H, Kawasaki K, Mikuni K, Ukai W, Murayama T, Hashimoto E, Utsumi K, Kawanishi C.
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [Abstract] [Full Text] [Related]

  • 2. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S, Hirao K, Kanetaka H, Namioka N, Hatanaka H, Hirose D, Fukasawa R, Umahara T, Sakurai H, Hanyu H.
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
    Tateno M, Kobayashi S, Shirasaka T, Furukawa Y, Fujii K, Morii H, Yasumura S, Utsumi K, Saito T.
    Dement Geriatr Cogn Disord; 2008 Jan; 26(5):453-7. PubMed ID: 18974648
    [Abstract] [Full Text] [Related]

  • 4. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C, SCILLA Working Group.
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
    Tang Z, Hirano S, Koizumi Y, Izumi M, Kitayama Y, Yamagishi K, Tamura M, Ishikawa A, Kashiwado K, Iimori T, Mukai H, Yokota H, Horikoshi T, Uno T, Kuwabara S.
    J Alzheimers Dis; 2024 Sep; 100(1):127-137. PubMed ID: 38848178
    [Abstract] [Full Text] [Related]

  • 6. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H, Shimizu S, Hirao K, Kanetaka H, Iwamoto T, Chikamori T, Usui Y, Yamashina A, Koizumi K, Abe K.
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
    [Abstract] [Full Text] [Related]

  • 7. [Improved diagnosis of dementia with Lewy bodies by the combination of 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 99mTc-ethylcysteinate dimmer (ECD) brain perfusion SPECT].
    Kobayashi S, Tateno M, Furukawa Y, Shirasaka T, Utumi K.
    Seishin Shinkeigaku Zasshi; 2008 Mar; 110(4):285-91. PubMed ID: 18593002
    [Abstract] [Full Text] [Related]

  • 8. A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
    Sakamoto F, Shiraishi S, Ogasawara K, Tsuda N, Nakagawa M, Tomiguchi S, Yamashita Y.
    Ann Nucl Med; 2020 Jun; 34(6):415-423. PubMed ID: 32301068
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
    Inui Y, Toyama H, Manabe Y, Sato T, Sarai M, Kosaka K, Iwata N, Katada K.
    J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141
    [Abstract] [Full Text] [Related]

  • 10. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
    Treglia G, Cason E, Cortelli P, Gabellini A, Liguori R, Bagnato A, Giordano A, Fagioli G.
    J Neuroimaging; 2014 Oct; 24(2):149-54. PubMed ID: 23163913
    [Abstract] [Full Text] [Related]

  • 11. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [123 I]-metaiodobenzylguanidine cardiac scintigraphy.
    Fujishiro H, Okuda M, Iwamoto K, Miyata S, Torii Y, Iritani S, Ozaki N.
    Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features?
    Sakamoto F, Shiraishi S, Tsuda N, Hashimoto M, Tomiguchi S, Ikeda M, Yamashita Y.
    Br J Radiol; 2017 Feb; 90(1070):20160156. PubMed ID: 27897064
    [Abstract] [Full Text] [Related]

  • 13. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Inui Y, Toyama H, Manabe Y, Sarai M, Iwata N.
    Ann Nucl Med; 2014 Oct; 28(8):796-804. PubMed ID: 24986482
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
    McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C, DLB Study Group.
    Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
    [Abstract] [Full Text] [Related]

  • 15. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J, Morgan S, Bradley KM, Noel-Storr AH, Ansorge O, Hyde C.
    Cochrane Database Syst Rev; 2015 Jan 30; 1(1):CD010633. PubMed ID: 25632881
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis of dementia with Lewy bodies: diagnostic performance of combined ¹²³I-IMP brain perfusion SPECT and ¹²³I-MIBG myocardial scintigraphy.
    Sakamoto F, Shiraishi S, Yoshida M, Tomiguchi S, Hirai T, Namimoto T, Hashimoto M, Ikeda M, Uetani H, Yamashita Y.
    Ann Nucl Med; 2014 Apr 30; 28(3):203-11. PubMed ID: 24363079
    [Abstract] [Full Text] [Related]

  • 17. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S, Kanetaka H, Hirao K, Fukasawa R, Namioka N, Hatanaka H, Hirose D, Umahara T, Sakurai H, Hanyu H.
    Geriatr Gerontol Int; 2017 May 30; 17(5):819-824. PubMed ID: 27138074
    [Abstract] [Full Text] [Related]

  • 18. Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies.
    Oda H, Ishii K, Terashima A, Shimada K, Yamane Y, Kawasaki R, Ohkawa S.
    Neurology; 2013 Nov 12; 81(20):1741-5. PubMed ID: 24122183
    [Abstract] [Full Text] [Related]

  • 19. Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease.
    Yoshii F, Ryo M, Baba Y, Koide T, Hashimoto J.
    J Neurol Sci; 2017 Apr 15; 375():80-85. PubMed ID: 28320195
    [Abstract] [Full Text] [Related]

  • 20. Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.
    Lebasnier A, Lamotte G, Manrique A, Peyronnet D, Bouvard G, Defer G, Agostini D.
    Eur J Nucl Med Mol Imaging; 2015 Jun 15; 42(7):1043-51. PubMed ID: 25626701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.